A Novel RXR Agonist, UAB30, Inhibits Rhabdomyosarcoma Cells in Vitro

BACKGROUND: While patients with early stage rhabdomyosarcoma (RMS) have seen steady improvement in prognosis over the last fifty years, those with advanced stage or high grade disease continue to have a dismal prognosis. Retinoids have been shown to cause growth suppression and terminal differentiat...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Surg Res
Main Authors: Williams, Adele P., Waters, Alicia M., Stewart, Jerry E., Atigadda, Venkatram R., Mroczek-Musulman, Elizabeth, Muccio, Donald D., Grubbs, Clinton J., Beierle, Elizabeth A.
格式: Artigo
語言:Inglês
出版: 2018
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007849/
https://ncbi.nlm.nih.gov/pubmed/29907230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2018.02.057
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍